AstraZeneca’s pivotal phase III MIRANDA trial of tozorakimab to treat COPD meets primary endpoint: Cambridge, UK Tuesday, April 21, 2026, 11:00 Hrs [IST] Positive high-level res ...
Some residents and businesses have opposed the scheme, which will also require road humps, islands and double yellow lines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results